Self-Management Interventions for Chronic Pain Relief With Cancer Survivors

The purpose of this randomized controlled trial is to evaluate if a 4-week recorded hypnosis
intervention (RHI) works for reducing chronic pain in 100 adult cancer survivors who have
completed active treatment. The RHI will be compared to an attention control condition
(relaxation recording). qEEG measurement will be obtained while listening to the RHI at weeks
0, 2, and 4 to explore if brain states are related to hypnotic analgesia during the 4-week
study period in 20 study participants.

The study has the following specific aims:

Aim 1: Does the RHI work? Evaluate the efficacy of RHI in reducing self-reported pain
intensity (primary outcome), pain interference, anxiety, depression, fatigue and sleep
disturbance (secondary outcomes) at 4 weeks compared to the attention control condition
(relaxation recording). Hypothesis: RHI will significantly reduce pain intensity, pain
interference, anxiety, depression, fatigue, and sleep disturbance at 4 weeks.

Aim 2: For whom does the RHI work? Examine if psychological factors (hypnotic suggestibility,
mental absorption, treatment outcome expectancy, fear of cancer recurrence, resilience,
self-efficacy) influence the relationship between RHI and pain intensity at weeks 0, 2, and
4.

Aim 3: How does the RHI work? a. Compare brain activity as measured by electroencephalogram
(EEG) in cancer survivors with chronic pain (n=20) receiving the RHI relative to the
attention control condition (relaxation recording) at weeks 0, 2, and 4. b. Explore the
effects of brain activity on pain intensity at weeks 0, 2, and 4. In addition, structured
interviews will be conducted with participants to understand facilitators and barriers
associated with undergoing EEG at three time points and perceptions on how the intervention
works to reduce pain.

Inclusion Criteria:

- self-reporting moderate or higher pain on average during the last week (> 3 on a 0-10
pain intensity numeric scale)

- self-reporting experiencing pain at least half of the days in the past 4 weeks

- self-reporting chronic pain related to cancer or its treatment

- completed active cancer treatment other than maintenance therapy

- being > 18 years of age

- functional fluency in English

- mentally and physically able to participate and complete surveys

Exclusion Criteria:

• has a psychiatric condition or symptoms (i.e., diagnosis of paranoid schizophrenia or
active paranoid delusional thoughts, as determined via a telephone or in-person screening
assessment) that would interfere with study participation.

Exclusion Criteria for Optional EEG Measurement:

- a history of seizure condition within the last year

- a significant brain injury or skull defect

- a history of brain cancer.